Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Polypoidal choroidal vasculopathy (PCV) is a common subtype of exudative age-related macular degeneration among Asian individuals. To our knowledge, there are no large randomized clinical trials to evaluate intravitreal ranibizumab, with and without verteporfin photodynamic therapy (vPDT), for the t...

Full description

Saved in:
Bibliographic Details
Main Authors: Adrian Koh, Timothy Y. Y. Lai, Kanji Takahashi, Tien Yin Wong, Lee-Jen Chen, Paisan Ruamviboonsuk, Colin S. Tan, Chrystel Feller, Philippe Margaron, Tock Han Lim, Won Ki Lee
Format: Artigo
Language:English
Published: 2017
Online Access:https://doi.org/10.1001/jamaophthalmol.2017.4030
https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2656454/jamaophthalmology_koh_2017_oi_170083.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1001/jamaophthalmol.2017.4030
https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2656454/jamaophthalmology_koh_2017_oi_170083.pdf

Similar Items